Skip to main content
Premium Trial:

Request an Annual Quote

GenomeDx Decipher GRID Tumor RNA Expression Profile Expansion

GenomeDx Biosciences has launched an expansion of its GRID Tumor RNA Expression Profile, a report generated for prostate tumors profiled with a Decipher Prostate Cancer Classifier test. The profile expansion features new markers and genomic signatures characterizing specific genomic attributes of the patients' prostate cancer, the company said. Profiles generated using the Classifier test are for research use only and will bed added to the company's cloud-based genomic data sharing and collaborative research platform, Decipher GRID, which contains over 27,000 tumor profiles and growing.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more